Debra A. Cafaro
Analyst · Bank of America
Thanks, Lori. Good morning. I'd like to echo Lori's welcome to all of our shareholders and other participants and thank you, for joining our call this morning. I'm pleased to share our record results for the quarter, introduce our increased guidance for the year and discuss our pending transactions. Following my remarks, Ray Lewis will discuss our portfolio and Rick Schweinheart will review our initial results in detail. As always, we'll then be pleased to answer your questions. Our second quarter financial results showcased the strength of our platform and our ability to continue to grow earnings, cash flow and our dividend, delivering superior results for our shareholders. First, let me address some of the highlights of the quarter. Normalized FFO grew 11% to $1.12 per share compared to the second quarter of last year. Our growth resulted from increases in same-store NOI, accretion from acquisitions and receipt of fees and other income. Excluding noncash items, normalized FFO also grew by 11%. We continued our long-standing focus on delivering reliable growing cash flow. Cash flow from operations grew 12% this quarter compared to the same period last year to $311 million and is up over 17% year-to-date. This extraordinary growth is due to our strong performance in raising capital effectively, investing capital wisely and managing our assets productively. Specifically, our same-store cash flow growth was 4.5% this quarter, and our weighted average cost of debt improved to 3.7%. In short, Ventas' financial performance continues to be consistent and outstanding. Turning to our investments. I'd like to highlight the benefits of our 2 pending acquisitions, totaling $3.8 billion. One is our acquisition of Holiday Retirements 29 independent living communities; and the second is our pending stock and cash acquisition of American Realty Capital Health Care Trust or HCT. These transactions solidified Ventas' position as the global leader in senior living and medical office buildings. I'd like to take some time to review our rationale for these transactions and discuss some of the positive characteristics of the assets and the capital structure for the deal. With these transactions, we are acquiring high-quality assets that are consistent with our strategy. The NOI from these assets is 87% private pay. Together, the transaction should provide at least $0.10 accretion to normalized funds from operations and funds available for distribution in 2015, assuming that we issue $1.8 billion of equity at the $67.13 per share valuation currently contemplated under the HCT merger agreement. As a result, these transactions will help us continue to grow cash flows and our dividend. The expected unlevered going-in cap rate on these transactions exceeds 6%, which is consistent with market pricing for high-quality private pay health care and senior living assets. In total, Holiday and HCT represent $3.8 billion of investments that will be funded with nearly 50% equity and the balance in cash or debt assumption. We have a BBB+ credit rating from all 3 rating agencies, and we believe our funding of these deals shows our commitment to retaining an excellent credit profile and rating. Continuing our balanced and diversified approach to capital allocation, the combined acquisitions generate 40% of their NOI from triple-net leased properties, 46% from senior housing operating communities and 14% from multi-tenant medical office buildings or MOBs. In terms of stability of cash flows, the triple-net leased portfolio has an average remaining lease term of 12 years and extremely limited near-term rollover. Importantly, we are also continuing to build an international business at Ventas, with 5% of our pro forma NOI derived from assets outside the U.S. Breaking the HCT and Holiday portfolios down to more granular pieces, here are some other important data points. The HCT portfolio, which is valued at $2.9 billion including its pipeline, is composed of high-quality newer assets that derive the vast majority of their NOI from private pay sources. The 4 million square feet of MOBs we're acquiring from HCT, fit our overall MOB strategy and my partner Todd Lillibridge is eager to bring those assets into his MOB fold. Here's why: they are 97% occupied, have average remaining lease terms of 8.3 years and half the buildings were newly constructed in the last 10 years. Each of these metrics improves the overall quality of our existing market-leading MOB portfolio. The MOBs are also consistent with our strategy because they are 90% affiliated or on campus with strong hospital sponsorship. Credit quality is also strong with, over, 70% of the NOI associated with investment-grade credits. In particular, the MOBs are affiliated with leading regional health systems, some of whom are already our clients and others, we are excited to do business with. They include Advocate, Taylor, Memorial Hermann and UC Davis. The HCT MOBs average over 50,000 square feet per building and are principally comprehensive or specialty outpatient centers that serve as a central hub for the affiliated health system's care network. They are strategically located to provide the convenience and access necessary for successful population health management. Currently, most of HCT's multitenant MOBs are managed by third parties and we see some potential upside to future property management insourcing because of our Lillibridge capabilities and scale. The HCT portfolio of 29 managed senior living assets are operated by 8 respected regional care providers. This portfolio is also high quality, with occupancy approximating 94% and NOI per unit per year of $16,700. It generates REVPOR per month of $4,300. These shop statistics compare favorably with NIC data and other wholly private pay portfolios without skilled nursing beds. We also like the local market demographics of the HCT senior living assets. They are in markets with above average concentrations of seniors and high expected growth in that cohort. We expect the NOI in these assets to grow at 4% to 5%. Turning to the Holiday assets. These apartment-like 29 independent living communities are also located in markets with exceedingly high percentages of seniors and they have robust median household income. Current occupancy in the portfolio exceeds 90%, and the properties have margins of about 50% and REVPOR of CAD 3,200 per month. The NOI growth rate is also expected to approximate 4% to 5%. We are excited to grow with Atria north of the border and they will take over the management of these Holiday communities at closing. In terms of funding and timing, we expect to complete the Holiday acquisition shortly, funded with proceeds of a Canadian dollar denominated bank facility we closed on July 31, and the assumption of mortgage debt. As soon as practicable, we expect to issue Canadian bonds to provide a long-term capital structure for the acquisition. We continue to expect to close the HCT acquisition in accordance with its terms probably late in the fourth quarter. As previously stated, the HCT transaction will be principally funded with $1.8 billion to $2 billion in Ventas equity, valued at $67.13 a share plus cash and assumed debt. This balanced deal structure is classic Ventas. It protects Ventas' shareholders and the accretion, eliminates equity market risks, fees and discounts; is balance sheet friendly; and allows HCT shareholders to participate in Ventas' future success. In sum, we are excited about our pending investments as we continue to build a high-quality reliable, diversified portfolio of productive health care and senior housing assets. Looking ahead, we are pleased to increase our full year 2014 normalized FFO guidance to $4.39 to $4.43 per share, as a result of our expected closing on Holiday and our results year-to-date. This guidance, if achieved, would deliver 7% to 8% per share normalized FFO growth over 2013, excluding noncash items. It would also represent the ninth year out of the last 11, when Ventas delivered over 7% per share growth. During that period, we have also grown our dividend at a compound annual rate exceeding 9%, and yet our payout ratio remains an exceptional 67% of normalized FFO per share excluding noncash items. We are confident we can extend our long track record of excellent, consistent performance to produce reliable growing cash flows, dividends, earnings and total return for our shareholders. With that, I'm delighted to turn the floor over to Ventas President, Ray Lewis.